LifeWatch AG

EANS-Adhoc: LifeWatch AG
LifeWatch AG´s shares will be included in the SXI LIFE SCIENCES® and the SXI Bio+Medtech® indices effective as of September 21, 2009 Inclusion in the indices of the SPI® Family remains unchanged

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide   distribution. The issuer is solely responsible for the content of this   announcement. --------------------------------------------------------------------------------@@end@@

Company Information

31.08.2009

Neuhausen am Rheinfall / Switzerland, August 31, 2009 - LifeWatch AG (SIX  Swiss Exchange: LIFE), the leading provider of wireless   cardiac  monitoring  services

@@start.t2@@in  the  U.S.,  announces  today  that  according  to    SIX    Swiss    Exchange's notification the LifeWatch shares will be included in the SXI LIFE SCIENCES  and the SXI Bio+Medtech indices effective as of September  21,  2009.  Inclusion  in the indices of the SPI Family remains unchanged.

The SXI Indices  Family  comprises  industry  sectors  that  are  of  particular significance to the Swiss economy; SXI stands for SIX Special Industry. The  SXI sector index family was launched in  2004  with  the  purpose  to  increase  the liquidity of shares listed on SIX Swiss Exchange that belong to  internationally significant industries@@end@@

The SXI LIFE SCIENCES and SXI Bio+Medtech  indices  reflect  the   life  sciences industry, one of Switzerland's most prominent sectors. The  weighting  of  each individual stock is capped at 10% giving   small  and  medium-sized  companies  a greater impact. The shares  of LifeWatch  AG  fulfil  the  following  inclusion criteria:

Minimum capitalization The SXI indices only include securities with a free float capitalization  of  at least CHF 100 million. Capitalization is calculated  on  the  basis  of  current information regarding the free float of securities available  on  the  benchmark date (July 31, 2009). To qualify  for  inclusion,  the   capitalization  must  at least amount to CHF 100 million on such a benchmark date and, in  addition,  the average capitalization during 20 trading days preceding the benchmark date  must also amount to at least CHF 100 million.

ICB sector classification Sector allocation is  based  on  the  ICB   (Industry  Classification  Benchmark) classification standard developed by  Dow  Jones  and  the  FTSE.  The  security universe of the two SXI indices encompasses one or  more  ICB  sub-sectors.  The respective sub-sectors are: 4533 Medical Providers / 4535  Medical   Equipment/ 4537 Medical Supplies / 4573 Biotechnology / 4577 Pharmaceuticals.

Free float In order to be included in one of the SXI indices, the   minimum  free  float  of the total shares of a given company must at least be 20%.

LifeWatch AG meets all the above mentioned criteria and its shares will  now  be included in the two SXI indices effective as of September 21, 2009.

About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed  on  SIX  Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and  solution company, specializing in  advanced  telehealth  systems  and  wireless  cardiac monitoring services. LifeWatch services  treat  high-risk  and  chronically  ill patients, health  conscious  consumers  and  wellness  programs. LifeWatch  has subsidiaries in the United States, the Netherlands, Japan, the  United  Kingdom, Switzerland and  Israel. LifeWatch  AG   is  the  parent  company  of  LifeWatch Services Inc., a leading   US-based  cardiac  monitoring  service  provider,  and manufacturer of telecardiology products. www.lifewatch.com

Sign-up for customized e-mail alerts and documentation requests is available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking  statements.  All   statements  other than statements of historical facts contained in this press  release,  including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations,  are forward-looking statements. The  words  "believe,"  "may,"  "will,"  "estimate," "continue,"   "anticipate,"  "intend,"  "expect"  and  similar  expressions    are intended to identify forward-looking statements. LifeWatch AG  has   based  these forward looking statements  largely  on  current   expectations  and  projections about future events and  financial   trends  that  it  believes  may  affect  the financial condition, results of operations, business strategy,  short  term  and long term business  operations  and  objectives,  and  financial  needs.  These forward-looking statements are subject to a number of risks,   uncertainties  and assumptions. In  light  of  these  risks,   uncertainties  and  assumptions,  the forward-looking events and circumstances described  may  not  occur  and  actual results could differ materially and adversely from those anticipated or  implied in the forward-looking statements.  All  forward-looking  statements   are  based only on data available to LifeWatch AG at the time of the issue  of  this  press release. LifeWatch AG does not undertake any obligation to update  any forward-looking  statements  contained  in this  press  release  as  a  result of  new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN  THE  UNITED  STATES  OF   AMERICA  AND SHOULD NOT BE DISTRIBUTED TO  UNITED  STATES  PERSONS   OR  PUBLICATIONS  WITH  A GENERAL  CIRCULATION  IN  THE  UNITED   STATES.  THIS  PRESS  RELEASE  DOES    NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR  ANY  OF  ITS  SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE  ANY SECURITIES OF LIFEWATCH  AG  OR  ITS  SUBSIDIARIES  IN  THE  UNITED   STATES.  IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND  ITS   SUBSIDIARIES  HAVE  NOT  BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED,  SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO  U.S.  PERSONS  ABSENT  REGISTRATION UNDER OR AN APPLICABLE EXEMPTION  FROM  THE  REGISTRATION  REQUIREMENTS  OF  THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE  MADE  IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT  MAY  BE  OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN  DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL  STATEMENTS OF THE ISSUER.

-----------------------

Press Release

August 31, 2009

@@start.t3@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG
Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | E-mail kobibe@lifewatch.com

Sensus Investor & Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.c

Branche: Healthcare Providers
ISIN:      CH0012815459
WKN:        1281545
Index:    SPI, SPIEX
Börsen:  Frankfurt / Open Market / XETRA
              SIX Swiss Exchange / Hauptsegment
              Berlin / free trade



Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: